FOUR COMPONENTS. ONE METABOLIC STACK.
The CARAT stack by Kovagen brings together cagrilintide, the metabolic blend, retatrutide and tesamorelin, with BAC water included. Five separate products for laboratory research.
For laboratory research only. Not for human consumption.
The CARAT combination has not been evaluated in clinical trials.
One vial of each. Choose your sizes below.
✓ Qualifies for free U.S. shipping
All 5 items added together. Review your cart before checkout.
For laboratory research use only. Not for human or veterinary consumption.
EVERY LETTER HAS A PURPOSE
CARAT is spelled out by the stack itself: Cagrilintide, Amino-1MQ, Retatrutide and Tesamorelin. Four compounds, four different mechanisms — amylin signaling, cellular metabolism, incretin receptor activity and visceral fat.
THE AMYLIN COMPONENT
Cagrilintide is an investigational long-acting amylin analog, studied as a co-agonist alongside GLP-1 receptor agonists in obesity research.
Cagrilintide is investigational and is not approved for any indication. The human data that exists comes from trials of investigational medicines, not from this vial.
Product details + certificatesTHE 5-AMINO-1MQ COMPONENT
The Metabolic blend supplies 5-Amino-1MQ alongside NAD+ and MOTS-c. 5-Amino-1MQ is a small molecule studied as an NNMT inhibitor in metabolic research, and it is not a peptide.
5-Amino-1MQ evidence is preclinical. NNMT inhibition has not been shown to produce metabolic outcomes in people, and the blend is supplied as one vial containing all three components.
Product details + certificatesTHE INCRETIN COMPONENT
Retatrutide is an investigational GLP-1, GIP and glucagon triple-receptor agonist being developed for obesity and metabolic disease.
Retatrutide remains investigational and is not FDA approved. Findings from clinical trials do not establish the effects of the CARAT combination.
Product details + certificatesTHE VISCERAL-FAT COMPONENT
Tesamorelin is a growth-hormone-releasing hormone analog studied for its effects on the GH/IGF-1 axis and visceral adipose tissue.
An FDA-approved tesamorelin medicine reduces excess abdominal fat in adults with HIV-associated lipodystrophy. That approval does not extend to these research vials or general weight-loss use.
Product details + certificatesWHERE THE EVIDENCE ACTUALLY STANDS
A stack page that implies its components share one evidence base is misleading. They do not. This is where each one stands today.
The four rows above describe different molecules, different study designs and different regulators. None of them describes this combination, which has not been studied at all.
THE BIGGER PICTURE
Your supplied collection covers four metabolic research areas, with every component listed clearly and BAC water already included.
A second satiety hormone pathway, separate from the incretins.
5-Amino-1MQ, NAD+ and MOTS-c in one vial.
Three receptor targets studied together in one molecule.
Fat around the abdominal organs, measured by imaging.
One vial each of cagrilintide, the Metabolic blend, retatrutide and tesamorelin, plus one vial of BAC water. The exact vial sizes and individual prices are shown in the stack builder.
The fourth letter is the ‘a’ in the word “and”: Cagrilintide, Amino-1MQ, Retatrutide and Tesamorelin. The Metabolic blend supplies the Amino-1MQ component together with NAD+ and MOTS-c in a single vial.
Yes. Where the catalog offers more than one size, choose your preferred option in the stack builder. The total updates immediately, and each click adds one vial of each selected product.
Neither. CARAT is a one-time purchase of separate products, with no recurring subscription. The Metabolic blend is one blended vial; every other component is supplied separately, and each line stays editable in your cart.
No. The combination has not been evaluated in clinical trials. Compounds in this stack sit at very different stages of research — one has an approved medicine behind it for a different indication, two are investigational, and one is preclinical. None of that transfers to this stack.
Each peptide’s product page links to its published batch certificates, and the Certificates library covers every released batch. U.S. orders ship with FedEx 2Day after dispatch; shipping to Canada uses FedEx International. Final shipping and applicable taxes are shown at checkout.
CAGRILINTIDE + AMINO-1MQ + RETATRUTIDE + TESAMORELIN
Four mechanisms. BAC water included.
Your metabolic stack, in one click.
CARAT is a collection of separate research compounds. The combination itself has not been evaluated in clinical trials. Cagrilintide and retatrutide remain investigational and are not FDA approved. Tesamorelin is FDA approved as a medicine for one specific indication unrelated to general weight-loss management; Kovagen’s research material is not that approved medicine. 5-Amino-1MQ is a small molecule studied preclinically and is not a peptide.
Kovagen products are sold for laboratory research purposes only and are not intended for human or veterinary consumption. Research areas described on this page are not promised outcomes or instructions for use. Questions about use in humans or animals are not answered, in any channel, including contact@kovagen.com.
